BSE - Delayed Quote INR

Vista Pharmaceuticals Limited (VISTAPH.BO)

Compare
10.93
-0.57
(-4.96%)
At close: 3:23:46 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Dr. Dhananjaya Alli Chairman and Whole-Time Director of Science & Technology -- -- 1950
Mr. Murali Meraga MD & Executive Director -- -- --
Mr. Pavan Sathvik Gilaka Whole-Time Director -- -- --
Mr. Suneel Pachipala Chief Financial Officer -- -- --
Ms. Barkha Jain Company Secretary & Compliance Officer -- -- --

Vista Pharmaceuticals Limited

Ravindra Co-operative Housing Society
Plot No: 104 Guttala Begumpet Kakatiya Hills
Hyderabad, 500033
India
91 40 2374 1585 https://www.vistapharmaceuticals.com
Sector: 
Healthcare

Description

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.

Corporate Governance

Vista Pharmaceuticals Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 26, 2025 at 10:59 AM UTC - May 30, 2025 at 12:00 PM UTC

Vista Pharmaceuticals Limited Earnings Date

Recent Events